<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2019-5-102-107</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2308</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РАЗНОЕ</subject></subj-group></article-categories><title-group><article-title>Эндотелий-зависимые молекулярные механизмы ремоделирования суставного хряща и субхондральной кости в условиях сердечно-сосудистой коморбидности</article-title><trans-title-group xml:lang="en"><trans-title>Endothelium-dependent molecular mechanisms of articular cartilage and subchondral bone remodeling in conditions of cardiovascular comorbidity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0054-0202</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кабалык</surname><given-names>М А</given-names></name><name name-style="western" xml:lang="en"><surname>Kabalyk</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент института терапии и инструментальной диагностики.</p><p>Владивосток, тел.: +7 (964) 439-79-27</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">maxi_maxim@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0117-0349</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Невзорова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nevzorova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Невзорова Вера Афанасьевна — доктор медицинских наук, профессор, директор института терапии и инструментальной диагностики.</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">Smu.tgmu@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6128-1737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коваленко</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalenko</surname><given-names>T. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коваленко Татьяна Сергеевна — лаборант центральной научно-исследовательской лаборатории, ординатор по специальности “терапия”.</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">Rheumatolog.ru.gg@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4933-5085</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суханова</surname><given-names>Г. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sukhanova</surname><given-names>G. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суханова Галина Ивановна — доктор медицинских наук, профессор института терапии и инструментальной диагностики.</p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">mk86prim@gmail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Тихоокеанский государственный медицинский университет Минздрава России</institution></aff><aff xml:lang="en"><institution>Pacific State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2019</year></pub-date><volume>18</volume><issue>5</issue><fpage>102</fpage><lpage>107</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кабалык М.А., Невзорова В.А., Коваленко Т.С., Суханова Г.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кабалык М.А., Невзорова В.А., Коваленко Т.С., Суханова Г.И.</copyright-holder><copyright-holder xml:lang="en">Kabalyk M.A., Nevzorova V.A., Kovalenko T.S., Sukhanova G.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2308">https://cardiovascular.elpub.ru/jour/article/view/2308</self-uri><abstract><sec><title>Цель</title><p>Цель. Определить уровень экспрессии эндотелиальных факторов (VEGF-A, CD34+) в тканях суставов при экспериментальной артериальной гипертонии (АГ), гиперлипидемии (ГЛ) и их сочетании.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Экспериментальное исследование проведено на 24 половозрелых самцах беспородных морских свинок. Все животные были разделены на 4 группы по 6 особей в каждой. В первой группе воспроизводили АГ путем внутримышечных инъекций раствора гидрокартизона. ГЛ у второй группы моделировали при внутрибрюшинной инъекции 1 раз в 3 нед. раствора Твин-80 и модификации рациона. В третьей группе воспроизводили сочетание АГ и ГЛ путем инъекций раствора гидрокартизона, Твин-80 и модификации рациона питания. На 60 сут. животные были выведены из эксперимента эвтаназией. Произведен забор тканей скакательных суставов задних конечностей, в которых с помощью перо-ксидазной иммуногистохимической реакции определяли экспрессию эндотелиального фактора роста сосудов A (VEGF-A), CD34.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что при экспериментальной АГ в субхондральной кости наблюдается повышенная экспрессия VEGF-A. При экспериментальной ГЛ в суставном хряще и субхондральной кости наблюдается преимущественная индукция VEGF-A и CD34. При комбинированном воздействии сердечно-сосудистых факторов наблюдается наиболее высокая экспрессия молекулярных механизмов кардиометаболического стресса, включая VEGF-A и CD34.</p></sec><sec><title>Заключение</title><p>Заключение. Получены результаты, свидетельствующие о том, что сердечно-сосудистые факторы оказывают влияние на суставные ткани. Это позволяет сделать предположение о принадлежности тканей суставов к органам-мишеням сердечно-сосудистых заболеваний и позволяют судить о важной роли сердечно-сосудистой коморбидности в патогенезе дегенеративно-воспалительных заболеваний суставов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To determine the expression level of endothelial factors (VEGF-A, CD34+) in the tissues of the joints in experimental arterial hypertension (AH), hyperlipidemia (HL) and their combination.</p></sec><sec><title>Material and methods</title><p>Material and methods. An experimental study was conducted on 24 sexually mature males of outbred guinea pigs. All animals were divided into 4 groups of 6 animals each. In the first group, AH was reproduced by intramuscular injection of a hydrocartisone solution. HL in the second group was simulated by intraperitoneal injection 1 time in 3 weeks of Tween 80 and diet modification. In the third group, the combination of AH and GL was reproduced by injection of a hydrocartisone solution, Tween-80 and diet modification. On the 60-day animals were pull out of the experiment by euthanasia. Hock joint tissue sampling was performed, in which the expression of endothelial vascular growth factor A (VEGF-A), CD34 was determined using a peroxidase immunohistochemical reaction.</p></sec><sec><title>Results</title><p>Results. It was found that during experimental AH, expression of VEGF-A increased in the subchondral bone. In experimental HL, preferential induction of VEGF-A and CD34 in the articular cartilage and subchondral bone is observed. When combined with cardiovascular factors, the highest expression of the molecular mechanisms of cardiometabolic stress, including VEGF-A and CD34 is observed.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results indicate that cardiovascular factors affect the joint tissue. This allows us to make an assumption that the joint tissues belong to the target organs of cardiovascular diseases and make it possible to judge the important role of cardiovascular comorbidity in the pathogenesis of degenerative inflammatory joint diseases.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>остеоартрит</kwd><kwd>артериальная гипертония</kwd><kwd>гиперлипидемия</kwd><kwd>суставной хрящ</kwd><kwd>субхондральная кость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>osteoarthritis</kwd><kwd>arterial hypertension</kwd><kwd>hyperlipidemia</kwd><kwd>articular cartilage</kwd><kwd>subchondral bone</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кабалык М. А. Распространенность остеоартрита в России: региональные аспекты динамики статистических показателей за 2011-2016 гг. Научно-практическая ревматология. 2018;56(4):416-22. doi:10.14412/1995-4484-2018-416-422.</mixed-citation><mixed-citation xml:lang="en">Kabalyk MA. Prevalence of osteoarthritis in Russia: regional aspects of the dynamics of statistical indicators for 2011-2016. Nauchno-Prakticheskaya Revmatologiya. 2018;56(4):416-22. (In Russ.) doi:10.14412/1995-4484-2018-416-422.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р. Г., Симаненков В. И., Бакулин И. Г. и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1 ):5-66. doi:10.15829/1728-8800-2019-1-5-66.</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019; 18(1):5-66. (In Russ.) doi:10.15829/1728-8800-2019-1-5-66.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem. 2000;275(26):20069-76.</mixed-citation><mixed-citation xml:lang="en">Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem. 2000;275(26):20069-76.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kabalyk MA. Molecular phenotypes of osteoarthritis. Osteoarthritis and Cartilage. 2018;26(1):173. doi:10.1016/j.joca.2018.02.376.</mixed-citation><mixed-citation xml:lang="en">Kabalyk MA. Molecular phenotypes of osteoarthritis. Osteoarthritis and Cartilage. 2018;26(1):173. doi:10.1016/j.joca.2018.02.376.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Radovanovic CA, dos Santos LA, Carvalho MD, Marcon SS. Arterial hypertension and other risk factors associated with cardiovascular diseases among adults. Rev Lat Am Enfermagem. 2014;22(4):547-53.</mixed-citation><mixed-citation xml:lang="en">Radovanovic CA, dos Santos LA, Carvalho MD, Marcon SS. Arterial hypertension and other risk factors associated with cardiovascular diseases among adults. Rev Lat Am Enfermagem. 2014;22(4):547-53.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Holwerda KM, Burke SD, Faas MM, et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J Am Soc Nephrol. 2014;25(4):717-25. doi:10.1681/ASN.2013030291.</mixed-citation><mixed-citation xml:lang="en">Holwerda KM, Burke SD, Faas MM, et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J Am Soc Nephrol. 2014;25(4):717-25. doi:10.1681/ASN.2013030291.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Daub K, Langer H, Seizer P, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J. 2006;20(14):2559-61.</mixed-citation><mixed-citation xml:lang="en">Daub K, Langer H, Seizer P, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J. 2006;20(14):2559-61.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marketou ME, Kalyva A, Parthenakis FI, et al. Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness. J Clin Hypertens (Greenwich). 2014;16(4):295-300. doi:10.1111/jch.12287.</mixed-citation><mixed-citation xml:lang="en">Marketou ME, Kalyva A, Parthenakis FI, et al. Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness. J Clin Hypertens (Greenwich). 2014;16(4):295-300. doi:10.1111/jch.12287.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Das RH, van Osch GJ, Kreukniet M, et al. Effects of individual control of pH and hypoxia in chondrocyte culture. J Orthop Res. 2010;28(4):537-45. doi: 10.1002/jor.20994.</mixed-citation><mixed-citation xml:lang="en">Das RH, van Osch GJ, Kreukniet M, et al. Effects of individual control of pH and hypoxia in chondrocyte culture. J Orthop Res. 2010;28(4):537-45. doi: 10.1002/jor.20994.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling — in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359-71.</mixed-citation><mixed-citation xml:lang="en">Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling — in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359-71.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kamei N, Atesok K, Ochi M. The Use of Endothelial Progenitor Cells for the Regeneration of Musculoskeletal and Neural Tissues. Stem Cells Int. 2017;2017:1960804. doi:10.1155/2017/1960804.</mixed-citation><mixed-citation xml:lang="en">Kamei N, Atesok K, Ochi M. The Use of Endothelial Progenitor Cells for the Regeneration of Musculoskeletal and Neural Tissues. Stem Cells Int. 2017;2017:1960804. doi:10.1155/2017/1960804.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005;67(5):1672-6.</mixed-citation><mixed-citation xml:lang="en">Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005;67(5):1672-6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Geurts J, Patel A, Hirschmann MT, et al. Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis. J Orthop Res. 2016;34(2):262-9. doi:10.1002/jor.23009.</mixed-citation><mixed-citation xml:lang="en">Geurts J, Patel A, Hirschmann MT, et al. Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis. J Orthop Res. 2016;34(2):262-9. doi:10.1002/jor.23009.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Studer D, Millan C, Ozturk E, et al. Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur Cell Mater. 2012;24:118-35.</mixed-citation><mixed-citation xml:lang="en">Studer D, Millan C, Ozturk E, et al. Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur Cell Mater. 2012;24:118-35.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110(10):1364-90. doi:10.1161/CIRCRESAHA.111.243972.</mixed-citation><mixed-citation xml:lang="en">Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110(10):1364-90. doi:10.1161/CIRCRESAHA.111.243972.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
